Vera Therapeutics Inc is a clinical stage biotechnology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
VERA is expected to report earnings to rise 13.16% to -172 cents per share on November 05
Q3'26
Est.
$-1.72
Q2'26
Beat
by $0.13
Q1'26
Missed
by $0.36
Q4'25
Missed
by $0.11
Q3'25
Missed
by $0.11
The last earnings report on August 10 showed earnings per share of -151 cents, beating the estimate of -164 cents. With 1.64M shares outstanding, the current market capitalization sits at 2.09B.